How have VUSE shares performed in 2024?

Vident U.S. Equity Strategy ETF's stock was trading at $51.09 at the beginning of 2024. Since then, VUSE shares have increased by 0.8% and is now trading at $51.5204. View the best growth stocks for 2024 here .

What does VUSE invest in?

Vident U.S. Equity Strategy ETF is a equity fund issued by Vident Financial. VUSE focuses on strategy investments and follows the Vident Quality U.S. Stock Index. The fund's investments total to approximately $546.30 million assets under management.

What stocks does Vident U.S. Equity Strategy ETF hold?

VUSE invests in 126 holdings. Some of the stocks in their portfolio include Exxon Mobil (XOM) , Adobe (ADBE) , Chevron (CVX) , JPMorgan Chase & Co. (JPM) , PepsiCo (PEP) , Broadcom (AVGO) , Amazon.com (AMZN) , Merck & Co., Inc. (MRK) , Coca-Cola (KO) and Mastercard (MA) .

What is the management fee for Vident U.S. Equity Strategy ETF?

Vident U.S. Equity Strategy ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for VUSE is 0.50%.

What other stocks do shareholders of Vident U.S. Equity Strategy ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vident U.S. Equity Strategy ETF investors own include ioneer (INR) , Bausch Health Companies (BHC) , Saul Centers (BFS) , Virtus LifeSci Biotech Products ETF (BBP) , Bellevue Healthcare (BBH) , Virtus LifeSci Biotech Clinical Trials ETF (BBC) , ArrowMark Financial (BANX) , Yamana Gold (AUY) , A. O. Smith (AOS) and Sphere 3D (ANY) .

Who are Vident U.S. Equity Strategy ETF's major shareholders?

Vident U.S. Equity Strategy ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Blue Trust Inc. (86.90%).

How do I buy shares of Vident U.S. Equity Strategy ETF?

Shares of VUSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:VUSE

Vident U.S. Equity Strategy ETF (VUSE) Price, Holdings, & News

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Free VUSE Stock Alerts

$51.52

-0.29 (-0.56%)

(As of 05/1/2024 ET)

Compare

Today's Range: $51.39
▼
$52.13
50-Day Range: $51.31
▼
$54.41
52-Week Range: $43.44
▼
$54.49

Volume: 34,758 shs
Average Volume: 19,914 shs
Market Capitalization: $546.12 million

Assets Under Management: $546.30 million
Dividend Yield: 1.26%
Net Expense Ratio: 0.50%

Stock Analysis Chart Headlines Holdings Ownership Ratings

Get Vident U.S. Equity Strategy ETF alerts:

About Vident U.S. Equity Strategy ETF (NYSEARCA:VUSE)

The Vident Core U.S. Equity Fund (VUSE) is an exchange-traded fund that is based on the Vident Core U.S. Stock index. The fund tracks an index of US companies selected and weighted based on a multi-factor model that considers corporate governance, quality, and momentum. VUSE was launched on Jan 22, 2014 and is managed by Vident.

VUSE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VUSE ETF News Headlines

April 27, 2024 | msn.com

YoY core PCE supports the status quo Fed Funds rate until later in the year - WF

April 24, 2024 | wsj.com

BNY Mellon US Equity Fund;Y

May 2, 2024 | MillPub (Ad)

😱 This phenomenon is smashing regular market gains

Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.

April 22, 2024 | investing.com

Russell Investments U.s. Core Equity Fund Class I (REASX)

April 18, 2024 | msn.com

Compare with Oak Harvest Long/Short Hedged Equity Fund;Ins (OHFGX)

April 10, 2024 | seekingalpha.com

VO: Mid-Caps Look Better Than Large-Caps, And So Does This Fund

March 27, 2024 | investing.com

Rbc U.s. Equity Fund D (RBF1022)

February 21, 2024 | msn.com

CVC launches sixth Asia fund as demand for private equity remains strong

May 2, 2024 | MillPub (Ad)

😱 This phenomenon is smashing regular market gains

Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.

December 16, 2023 | wsj.com

Invesco Global Core Equity Fund;A

See More Headlines

Receive VUSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vident U.S. Equity Strategy ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Vident Financial
Fund Name: Vident Core U.S. Equity Fund
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:VUSE
Inception Date: 1/21/2014
Fund Manager: Denise M. Krisko
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Vident Quality U.S. Stock Index
Category: Broad Equity
Focus: Strategy
Development Level: Developed Markets
Region: North America
Number of Holdings: 126

Fund Statistics

Assets Under Management: $546.30 million
Average Daily Volume: $20,423.10
Discount/Premium: 0.15%

Administrator, Advisor and Custodian

Administrator: U.S. Bancorp Fund Services, LLC
Advisor: Exchange Traded Concepts, LLC
Custodian: U.S. Bank, N.A.
Distributor: Quasar Distributors, LLC
Transfer Agent: U.S. Bank, N.A.
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: N/A
Short Interest: 3,500 shs

Miscellaneous

Outstanding Shares: 10,600,000
Beta: 0.94
Creation Unit: 100,000
Creation Fee: $750.00

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Vident U.S. Equity Strategy ETF Expenses

Type	VUSE	Strategy ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.50%	0.46%	0.54%	0.50%	0.51%
Other Expenses	0.00%	0.42%	0.54%	0.64%	0.58%
Total Expense	0.50%	0.61%	0.70%	0.74%	0.70%
Fee Waiver	0.00%	-0.44%	-0.55%	-0.68%	-0.57%
Net Expense	0.50%	0.51%	0.60%	0.58%	0.58%

Vident U.S. Equity Strategy ETF (VUSE) Holdings & Exposure

Top 10 VUSE Holdings

VUSE Sector Exposure

VUSE Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

VUSE ETF - Frequently Asked Questions

How have VUSE shares performed in 2024?: Vident U.S. Equity Strategy ETF's stock was trading at $51.09 at the beginning of 2024. Since then, VUSE shares have increased by 0.8% and is now trading at $51.5204.
View the best growth stocks for 2024 here.
What does VUSE invest in?: Vident U.S. Equity Strategy ETF is a equity fund issued by Vident Financial. VUSE focuses on strategy investments and follows the Vident Quality U.S. Stock Index. The fund's investments total to approximately $546.30 million assets under management.
What stocks does Vident U.S. Equity Strategy ETF hold?: VUSE invests in 126 holdings. Some of the stocks in their portfolio include Exxon Mobil (XOM), Adobe (ADBE), Chevron (CVX), JPMorgan Chase & Co. (JPM), PepsiCo (PEP), Broadcom (AVGO), Amazon.com (AMZN), Merck & Co., Inc. (MRK), Coca-Cola (KO) and Mastercard (MA).
What is the management fee for Vident U.S. Equity Strategy ETF?: Vident U.S. Equity Strategy ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for VUSE is 0.50%.

What other stocks do shareholders of Vident U.S. Equity Strategy ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Vident U.S. Equity Strategy ETF investors own include ioneer (INR), Bausch Health Companies (BHC), Saul Centers (BFS), Virtus LifeSci Biotech Products ETF (BBP), Bellevue Healthcare (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), ArrowMark Financial (BANX), Yamana Gold (AUY), A. O. Smith (AOS) and Sphere 3D (ANY).
Who are Vident U.S. Equity Strategy ETF's major shareholders?: Vident U.S. Equity Strategy ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Blue Trust Inc. (86.90%).
How do I buy shares of Vident U.S. Equity Strategy ETF?: Shares of VUSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:VUSE) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial